Measuring the Treatment Preferences of Participants in Japan With Moderate-to-Severe Psoriasis (PsO) Using Discrete Choice Experiment

Patient Preference for Treatment of Moderate-To-Severe Psoriasis in Japan

The purpose of this observational study is to identify and weight the treatment attributes from the moderate-to-severe Psoriasis (PsO) patients' perspective in Japan.

Inclusion Criteria:

• Diagnosis of moderate-to-severe Psoriasis (PsO) by physician (phase 1) or self-reported (phase 2)
• Currently taking systemic psoriasis treatment
• Japanese resident aged 20 years and older

Exclusion Criteria:

• Unable or unwilling to provide informed consent
• Diagnosis of guttate, inverse, pustular, erythrodermic, or drug-induced psoriasis